Why the study?
Does iodine-123 MIBG myocardial imaging predict the effectiveness and tolerability of beta-blocker treatment in patients with idiopathic dilated cardiomyopathy?
Population
27 patients with idiopathic dilated cardiomyopathy who are candidates for beta-blocker treatment
Design
Cohort
Follow-up
3 months
Authors
Loading...
May aid beta-blocker tolerance prediction in dilated cardiomyopathy; leaves open need for randomized outcome trials.
Does iodine-123 MIBG myocardial imaging predict the effectiveness and tolerability of beta-blocker treatment in patients with idiopathic dilated cardiomyopathy?
MIBG myocardial imaging may help identify patients with idiopathic dilated cardiomyopathy who are likely to tolerate and benefit from beta-blocker therapy.
Kakuchi et al. (1999) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: